Anggot, Cecillia .

HRN: 17-87-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/04/2025
04/11/2025
IV
4.5 Gram
Q8h
CAP MR
Rejected 
04/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2025
04/11/2025
IVT
4.5g
Q6
Sepsis Sec To Non Healing Wound Right Foot
Waiting Final Action 
04/08/2025
MUPIROCIN 2%, 15G (TUBE)
04/08/2025
04/14/2025
TOPICAL
15g
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: